Quantcast

Posts related to ‘cancer treatments’

biotech

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Posted: February 8, 2013 at 10:10 am

Investing in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary ...
Read Full Story »
health care

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

Posted: January 18, 2013 at 9:50 am

The dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is the number two cause of death in Americans, second only ...
Read Full Story »

Dendreon In Trouble

Posted: May 17, 2012 at 11:35 am

Dendreon Corporation (NASDAQ: DNDN) is in trouble.  That is what the performance is telling investors.  The maker of Provenge as a late-stage prostate cancer treatment has three issues working against ...
Read Full Story »